Patent ID: 8546321

Claim:
A method for treatment of inflammatory diseases or conditions comprising administration, to an individual in need thereof, of a compound having one or more peptides, each peptide consisting of a sequence selected from the group consisting of AQFHRHKQLIRFLKRA (SEQ ID NO: 1), RNKQVIDSLAKFLKR (SEQ ID NO: 19), ARFLKRLDRNLWGG (SEQ ID NO: 3), KRLQQNLFGG (SEQ ID NO: 6), and Ac-AQFHRHKQLIRFLKRA (SEQ ID NO: 7), or a variant of said sequence, said variant being substituted at 1 amino acid position with a conservative amino acid substitution, wherein said compound is capable of decreasing LPS-induced TNF-alpha release by macrophages.